Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Creatinine and Potassium Levels After Initiation of RAASIs for Chronic Kidney Disease
11/10/2018
A new study showed increases in creatinine levels and hyperkalemia after initiation of RAASIs therapy were not associated with emergency department visits or hospitalizations, despite being a common reason for discontinuation of this therapy.
A new study showed increases in creatinine levels and hyperkalemia after initiation of RAASIs therapy were not associated with emergency department visits or hospitalizations, despite being a common reason for discontinuation of this therapy.
A new study showed increases in...
11/10/2018
Pharmacy Learning Network
News
Mylan and Theravance`s COPD Treatment Gets FDA Approval
11/09/2018
The FDA has approved a once-daily inhalable solution for the treatment of chronic obstructive pulmonary disease.
The FDA has approved a once-daily inhalable solution for the treatment of chronic obstructive pulmonary disease.
The FDA has approved a...
11/09/2018
Pharmacy Learning Network

Advertisement

News
IV Pain Med Pulled
11/08/2018
Over 1300 bags of an intravenous pain reliever used to manage acute pain are being recalled. 
Over 1300 bags of an intravenous pain reliever used to manage acute pain are being recalled. 
Over 1300 bags of an...
11/08/2018
Pharmacy Learning Network
News
Opioid Solution Recalled
11/08/2018
A Class II recall is active for a narcotic pain reliever used to treat moderate to severe pain.
A Class II recall is active for a narcotic pain reliever used to treat moderate to severe pain.
A Class II recall is active...
11/08/2018
Pharmacy Learning Network
News
Analgesic Solution Recalled
11/08/2018
A prescription pain medication is being recalled. 
A prescription pain medication is being recalled. 
A prescription pain medication...
11/08/2018
Pharmacy Learning Network

Advertisement

News
Surgical Hypotension Drug Recalled
11/08/2018
A drug used to treat low blood pressure that occurs during surgery is being recalled. 
A drug used to treat low blood pressure that occurs during surgery is being recalled. 
A drug used to treat low blood...
11/08/2018
Pharmacy Learning Network
News
Hypertension Drug Recalled
11/08/2018
The FDA is recalling a prescription alpha-agonist hypotensive agent used to treat high blood pressure.
The FDA is recalling a prescription alpha-agonist hypotensive agent used to treat high blood pressure.
The FDA is recalling a...
11/08/2018
Pharmacy Learning Network
News
Prescription Size is a Better Predictor of Opioid Use Than Pain Level
11/08/2018
In a recent study, researchers sought to examine opioid prescribing and consumption following surgery and to determine factors associated with opioid consumption.
In a recent study, researchers sought to examine opioid prescribing and consumption following surgery and to determine factors associated with opioid consumption.
In a recent study, researchers...
11/08/2018
Pharmacy Learning Network

Advertisement

News
Experimental Antibiotic Effective Against Gonorrhea in Early Trial
11/07/2018
An experimental anti-gonorrhea drug was able to cure the infection in more than 90% of patients according to a recent study.
An experimental anti-gonorrhea drug was able to cure the infection in more than 90% of patients according to a recent study.
An experimental anti-gonorrhea...
11/07/2018
Pharmacy Learning Network
News
CDC: Reported Cases of Flaccid Myelitis Increases
11/07/2018
The CDC has received 219 reports of acute flaccid myelitis, which is nearly 30 more from the week prior.
The CDC has received 219 reports of acute flaccid myelitis, which is nearly 30 more from the week prior.
The CDC has received 219 reports...
11/07/2018
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use